| Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
|---|
| Lipoic-acid | hsa00280 | Valine, leucine and isoleucine degradation | 4.31E-02 | 3 | Q9HCC0, Q02252, P11310 | MCCC2, ALDH6A1, ACADM | More | | | Lipoic-acid | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | | Lipoic-acid | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.21E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | | Lipoic-acid | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 9.01E-03 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | | Lipoic-acid | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | | Lipoic-acid | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | | Lipoic-acid | hsa00983 | Drug metabolism - other enzymes | 1.72E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | | Lipoic-acid | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | | Lipoic-acid | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | | Lipoic-acid | hsa04064 | NF-kappa B signaling pathway | 3.23E-02 | 7 | P10415, Q12933, Q13546, Q9UDY8, Q13077, P10145, P19784 | BCL2, TRAF2, RIPK1, MALT1, TRAF1, IL8, CSNK2A2 | More | | | Lipoic-acid | hsa04071 | Sphingolipid signaling pathway | 4.94E-02 | 5 | Q9BX95, P04637, P10415, Q86VZ5, Q12933 | SGPP1, TP53, BCL2, SGMS1, TRAF2 | More | | | Lipoic-acid | hsa04114 | Oocyte meiosis | 2.19E-02 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | | Lipoic-acid | hsa04370 | VEGF signaling pathway | 1.35E-02 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | | Lipoic-acid | hsa04622 | RIG-I-like receptor signaling pathway | 1.76E-03 | 5 | P01568, Q9H1Y0, Q13546, Q12933, P10145 | IFNA21, ATG5, RIPK1, TRAF2, IL8 | More | | | Lipoic-acid | hsa04914 | Progesterone-mediated oocyte maturation | 2.81E-02 | 4 | Q17RY0, Q9Y6D9, P51812, Q02750 | CPEB4, MAD1L1, RPS6KA3, MAP2K1 | More | | | Lipoic-acid | hsa05131 | Shigellosis | 4.92E-02 | 6 | Q9NQL2, P0CG47, Q14141, Q96JJ3, Q05397, Q13315 | RRAGD, UBB, SEPT6, ELMO2, PTK2, ATM | More | | | Lipoic-acid | hsa05132 | Salmonella infection | 1.96E-02 | 10 | P10145, P57764, Q12933, Q13546, P10415, O75369, O60603, P51808, Q13561, Q13509 | IL8, GSDMDC1, TRAF2, RIPK1, BCL2, FLNB, TLR2, DYNLT3, DCTN2, TUBB3 | More | | | Lipoic-acid | hsa05133 | Pertussis | 3.88E-03 | 4 | P05107, P0DP23, P10145, P0C0L4 | ITGB2, CALM1, IL8, C4A | More | | | Lipoic-acid | hsa05144 | Malaria | 3.88E-03 | 5 | P69905, P68871, O60603, P05107, P10145 | HBA2, HBB, TLR2, ITGB2, IL8 | More | | | Lipoic-acid | hsa05152 | Tuberculosis | 1.86E-02 | 8 | P0DP23, P05107, P48382, P25208, O60603, P10415, P01568, Q9UDY8 | CALM1, ITGB2, RFX5, NFYB, TLR2, BCL2, IFNA21, MALT1 | More | | | Lipoic-acid | hsa05170 | Human immunodeficiency virus 1 infection | 1.65E-02 | 6 | Q02750, P62879, P16298, Q05397, Q13315, P23528 | MAP2K1, GNB2, PPP3CB, PTK2, ATM, CFL1 | More | | | Lipoic-acid | hsa05203 | Viral carcinogenesis | 4.62E-02 | 3 | Q12933, P42229, Q15283 | TRAF2, STAT5A, RASA2 | More | | | Lipoic-acid | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | |
|
